BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14311922)

  • 1. [CLINICAL EXPERIENCES WITH TALUSIN].
    GEBHARDT W; REINDELL H; HEINING J; BUECHNER C; DANNER D; MOSER F; WOEHLER F; HOFFMANN G; WINCKELMANN G
    Med Klin; 1965 May; 60():893-8. PubMed ID: 14311922
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICAL EXPERIENCES WITH TALUSIN. 2].
    GEBHARDT W; DANNER D; MOSER F; REINDELL H; HEINING J; BUECHNER C; WOEHLER F; HOFFMAN G; WINCKELMANN G
    Med Klin; 1965 Jun; 60():964-9. PubMed ID: 14304966
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON CARDIAC THERAPY WITH TALUSIN: WITH SPECIAL REFERENCE TO CHRONIC COR PULMONALE].
    BOPP KP
    Munch Med Wochenschr; 1964 Dec; 106():2265-7. PubMed ID: 14343363
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON THE EFFECTIVENESS OF PROSCILLARIDIN A].
    SAMEC V
    Wien Med Wochenschr; 1965 Feb; 115():184-8. PubMed ID: 14266172
    [No Abstract]   [Full Text] [Related]  

  • 5. [Talusin (proscillaridin)--once more].
    Bakke O; Rasmussen K
    Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2576-7. PubMed ID: 5138790
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON PHARMACOLOGY AND THE THERAPEUTIC USE OF PROSCILLARIDIN A].
    KUBICEK F; LINDNER A; POLZER K
    Wien Klin Wochenschr; 1965 Jan; 77():12-6. PubMed ID: 14273290
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proscillaridin A immunoreactivity: a new endogenous cardiac glycoside?
    Li SQ; Eim C; Schneider R; Sich B; Kirch U; Schoner W
    Ann N Y Acad Sci; 1997 Nov; 834():646-7. PubMed ID: 9405880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic experiences with a new cardiac glycoside: proscillaridin A].
    Meier G; Wagner G
    Med Welt; 1965 Aug; 35():1995-2002. PubMed ID: 5847514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
    Amirfallah A; Einert HJ
    Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
    Erdmann E
    Arzneimittelforschung; 1978; 28(3a):531-5. PubMed ID: 148278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic note on the use of talusin and theo-talusin in ambulatory patients].
    Wirthner H
    Praxis; 1969 Oct; 58(42):1350-1. PubMed ID: 5396158
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic experiences with proscillaridin A in decompensated heart diseases].
    Verga L; Forzani GF
    Minerva Med; 1967 Dec; 58(96):4318-22. PubMed ID: 6083293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with the clinical use of proscillaridin A].
    Milde HW
    Med Welt; 1969 Mar; 10():531-5. PubMed ID: 5814419
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy.
    Bonelli J; Magometschnig D; Gazo F
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):243-5. PubMed ID: 3410600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observations on a new cardiotonic drug (Talusin)].
    Amoroso A; Ghiara F
    Minerva Med; 1966 Oct; 57(81):3301-4. PubMed ID: 5955198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
    Grujić M; Perinović M; Ljubojević S
    Med Arh; 1977; 31(3):171-5. PubMed ID: 333198
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern cardiac glycoside therapy].
    Bonelli J
    Wien Med Wochenschr; 1978; 128(22):689-96. PubMed ID: 735108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.